ArticleCancer drug resistance (Alhambra, Calif.)2024

Overcoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer model.

Guillaume Sicard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.